-
1
-
-
39549097301
-
Triiodothyronine levels in athyreotic individuals during levothyroxine therapy
-
Jonklaas J, Davidson B, Bhagat S, Soldin SJ 2008 Triiodothyronine levels in athyreotic individuals during levothyroxine therapy. JAMA 299:769-777.
-
(2008)
JAMA
, vol.299
, pp. 769-777
-
-
Jonklaas, J.1
Davidson, B.2
Bhagat, S.3
Soldin, S.J.4
-
2
-
-
79960953366
-
Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients
-
Gullo D, Latina A, Frasca F, Le Moli R, Pellegriti G, Vigneri R 2011 Levothyroxine monotherapy cannot guarantee euthyroidism in all athyreotic patients. PLoS One 6:e22552.
-
(2011)
PLoS One
, vol.6
, pp. e22552
-
-
Gullo, D.1
Latina, A.2
Frasca, F.3
Le Moli, R.4
Pellegriti, G.5
Vigneri, R.6
-
3
-
-
84865756960
-
TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy
-
Ito M, Miyauchi A, Morita S, Kudo T, Nishihara E, Kihara M, Takamura Y, Ito Y, Kobayashi K, Miya A, Kubota S, Amino N 2012 TSH-suppressive doses of levothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur J Endocrinol 167:373-378.
-
(2012)
Eur J Endocrinol
, vol.167
, pp. 373-378
-
-
Ito, M.1
Miyauchi, A.2
Morita, S.3
Kudo, T.4
Nishihara, E.5
Kihara, M.6
Takamura, Y.7
Ito, Y.8
Kobayashi, K.9
Miya, A.10
Kubota, S.11
Amino, N.12
-
4
-
-
0036123394
-
Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations
-
Woeber KA 2002 Levothyroxine therapy and serum free thyroxine and free triiodothyronine concentrations. J Endocrinol Invest 25:106-109.
-
(2002)
J Endocrinol Invest
, vol.25
, pp. 106-109
-
-
Woeber, K.A.1
-
5
-
-
84874510511
-
Is pituitary TSH an adequate measure of thyroid hormonecontrolled homoeostasis during thyroxine treatment?
-
Hoermann R, Midgley JE, Larisch R, Dietrich JW 2013 Is pituitary TSH an adequate measure of thyroid hormonecontrolled homoeostasis during thyroxine treatment? Eur J Endocrinol 168:271-280.
-
(2013)
Eur J Endocrinol
, vol.168
, pp. 271-280
-
-
Hoermann, R.1
Midgley, J.E.2
Larisch, R.3
Dietrich, J.W.4
-
6
-
-
35948960311
-
Thyroid hormone replacement for central hypothyroidism: A randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine
-
Slawik M, Klawitter B, Meiser E, Schories M, Zwermann O, Borm K, Peper M, Lubrich B, Hug MJ, Nauck M, Olschewski M, Beuschlein F, Reincke M 2007 Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine. J Clin Endocrinol Metab 92:4115-4122.
-
(2007)
J Clin Endocrinol Metab
, vol.92
, pp. 4115-4122
-
-
Slawik, M.1
Klawitter, B.2
Meiser, E.3
Schories, M.4
Zwermann, O.5
Borm, K.6
Peper, M.7
Lubrich, B.8
Hug, M.J.9
Nauck, M.10
Olschewski, M.11
Beuschlein, F.12
Reincke, M.13
-
7
-
-
58149466267
-
Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism
-
Iverson JF, Mariash CN 2008 Optimal free thyroxine levels for thyroid hormone replacement in hypothyroidism. Endocr Pract 14:550-555.
-
(2008)
Endocr Pract
, vol.14
, pp. 550-555
-
-
Iverson, J.F.1
Mariash, C.N.2
-
8
-
-
84873988744
-
Using body mass index to predict optimal thyroid dosing after thyroidectomy
-
Ojomo KA, Schneider DF, Reiher AE, Lai N, Schaefer S, Chen H, Sippel RS 2013 Using body mass index to predict optimal thyroid dosing after thyroidectomy. J Am Coll Surg 216:454-460.
-
(2013)
J Am Coll Surg
, vol.216
, pp. 454-460
-
-
Ojomo, K.A.1
Schneider, D.F.2
Reiher, A.E.3
Lai, N.4
Schaefer, S.5
Chen, H.6
Sippel, R.S.7
-
9
-
-
48549103825
-
Maternal thyroid hypofunction and pregnancy outcome
-
Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW, D'Alton ME 2008 Maternal thyroid hypofunction and pregnancy outcome. Obstet Gynecol 112:85-92.
-
(2008)
Obstet Gynecol
, vol.112
, pp. 85-92
-
-
Cleary-Goldman, J.1
Malone, F.D.2
Lambert-Messerlian, G.3
Sullivan, L.4
Canick, J.5
Porter, T.F.6
Luthy, D.7
Gross, S.8
Bianchi, D.W.9
D'Alton, M.E.10
-
10
-
-
45549084841
-
First- and second-trimester thyroid hormone reference data in pregnant women: A FaSTER (First- and second-trimester evaluation of risk for aneuploidy) research consortium study
-
Lambert-Messerlian G, McClain M, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME 2008 First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 199:62.e61-66.
-
(2008)
Am J Obstet Gynecol
, vol.199
, pp. 62-66
-
-
Lambert-Messerlian, G.1
McClain, M.2
Haddow, J.E.3
Palomaki, G.E.4
Canick, J.A.5
Cleary-Goldman, J.6
Malone, F.D.7
Porter, T.F.8
Nyberg, D.A.9
Bernstein, P.10
D'Alton, M.E.11
-
11
-
-
47949126441
-
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: A FaSTER trial study
-
McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D'Alton ME 2008 Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol 199:129 e121-126.
-
(2008)
Am J Obstet Gynecol
, vol.199
, Issue.129
, pp. e121-126
-
-
McClain, M.R.1
Lambert-Messerlian, G.2
Haddow, J.E.3
Palomaki, G.E.4
Canick, J.A.5
Cleary-Goldman, J.6
Malone, F.D.7
Porter, T.F.8
Nyberg, D.A.9
Bernstein, P.10
D'Alton, M.E.11
-
12
-
-
0020042306
-
Chemical hyperthyroidism: Serum triiodothyronine levels in clinically euthyroid individuals treated with levothyroxine
-
Salmon D, Rendell M, Williams J, Smith C, Ross DA, Waud JM, Howard JE 1982 Chemical hyperthyroidism: serum triiodothyronine levels in clinically euthyroid individuals treated with levothyroxine. Arch Intern Med 142: 571-573.
-
(1982)
Arch Intern Med
, vol.142
, pp. 571-573
-
-
Salmon, D.1
Rendell, M.2
Williams, J.3
Smith, C.4
Ross, D.A.5
Waud, J.M.6
Howard, J.E.7
-
13
-
-
0023103073
-
Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans
-
Fish LH, Schwartz HL, Cavanaugh J, Steffes MW, Bantle JP, Oppenheimer JH 1987 Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. N Engl J Med 316:764-770.
-
(1987)
N Engl J Med
, vol.316
, pp. 764-770
-
-
Fish, L.H.1
Schwartz, H.L.2
Cavanaugh, J.3
Steffes, M.W.4
Bantle, J.P.5
Oppenheimer, J.H.6
-
14
-
-
84901484766
-
Treatment with thyroid hormone
-
Biondi B, Wartofsky L 2014 Treatment with thyroid hormone. Endocr Rev 35:433-512.
-
(2014)
Endocr Rev
, vol.35
, pp. 433-512
-
-
Biondi, B.1
Wartofsky, L.2
-
15
-
-
84873627350
-
Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy
-
Haddow JE, Craig WY, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, D'Alton ME 2013 Impact of adjusting for the reciprocal relationship between maternal weight and free thyroxine during early pregnancy. Thyroid 23:225-230.
-
(2013)
Thyroid
, vol.23
, pp. 225-230
-
-
Haddow, J.E.1
Craig, W.Y.2
Palomaki, G.E.3
Neveux, L.M.4
Lambert-Messerlian, G.5
Canick, J.A.6
Malone, F.D.7
D'Alton, M.E.8
-
16
-
-
79952425156
-
Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population
-
Mannisto T, Surcel HM, Ruokonen A, Vaarasmaki M, Pouta A, Bloigu A, Jarvelin MR, Hartikainen AL, Suvanto E 2011 Early pregnancy reference intervals of thyroid hormone concentrations in a thyroid antibody-negative pregnant population. Thyroid 21:291-298.
-
(2011)
Thyroid
, vol.21
, pp. 291-298
-
-
Mannisto, T.1
Surcel, H.M.2
Ruokonen, A.3
Vaarasmaki, M.4
Pouta, A.5
Bloigu, A.6
Jarvelin, M.R.7
Hartikainen, A.L.8
Suvanto, E.9
-
17
-
-
84910683683
-
Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects
-
Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F 2014 Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid 24: 1566-1574.
-
(2014)
Thyroid
, vol.24
, pp. 1566-1574
-
-
Mehran, L.1
Amouzegar, A.2
Tohidi, M.3
Moayedi, M.4
Azizi, F.5
-
18
-
-
84870784432
-
Clinical practice guidelines for hypothyroidism in adults: Cosponsored by the American association of clinical endocrinologists and the American thyroid association
-
Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI, Pessah-Pollack R, Singer PA, Woeber KA; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults 2012 Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Thyroid 22:1200-1235.
-
(2012)
Thyroid
, vol.22
, pp. 1200-1235
-
-
Garber, J.R.1
Cobin, R.H.2
Gharib, H.3
Hennessey, J.V.4
Klein, I.5
Mechanick, J.I.6
Pessah-Pollack, R.7
Singer, P.A.8
Woeber, K.A.9
-
19
-
-
84863583977
-
Combination treatment with T4 and T3: Toward personalized replacement therapy in hypothyroidism?
-
Biondi B, Wartofsky L 2012 Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? J Clin Endocrinol Metab 97:2256-2271.
-
(2012)
J Clin Endocrinol Metab
, vol.97
, pp. 2256-2271
-
-
Biondi, B.1
Wartofsky, L.2
-
20
-
-
84871046753
-
2012 ETA guidelines: The use of LT4 + L-T3 in the treatment of hypothyroidism
-
Wiersinga WM, Duntas L, Fadeyev V, Nygaard B, Vanderpump MP 2012 2012 ETA Guidelines: the use of LT4 + L-T3 in the treatment of hypothyroidism. Eur Thyroid J 1:55-71.
-
(2012)
Eur Thyroid J
, vol.1
, pp. 55-71
-
-
Wiersinga, W.M.1
Duntas, L.2
Fadeyev, V.3
Nygaard, B.4
Vanderpump, M.P.5
|